Related by context. Frequent words. (Click for all words.) 67 tolerated dose MTD 64 eniluracil 64 CR# vcMMAE 63 nab paclitaxel 63 dosing regimens 63 tanespimycin 63 Azedra 61 dose escalation 61 noninferiority 61 registrational 61 PXD# 61 Neuradiab 61 efficacy 60 CoFactor 60 placebo controlled clinical 60 safety tolerability pharmacokinetics 60 tipranavir 60 limiting toxicity 60 dosing schedules 59 dose regimens 59 PREOS 59 rNAPc2 59 NGX# 59 Asentar 59 pharmacokinetic profile 59 neoadjuvant 59 imetelstat 59 tolerability 59 temsirolimus 58 randomized controlled clinical trials 58 HGS ETR1 58 tezampanel 58 genotoxicity 58 Menerba 58 Phase 1b trial 58 Allovectin 7 R 58 confirmatory Phase III 58 decitabine 58 axitinib 58 clinical endpoints 58 Icatibant 58 rHuPH# 58 thymalfasin 58 SCH # 58 antitumor activity 58 teduglutide 58 aflibercept 58 Combination therapy 57 Phase 2a trial 57 pharmacodynamics 57 dose limiting toxicities 57 MAXY G# 57 CA4P 57 active comparator 57 vandetanib 57 IMGN# 57 vicriviroc 57 adjuvant therapy 57 pharmacokinetic studies 57 Amigal 57 placebo controlled studies 57 Zerenex 57 Phenoptin 57 dosing regimen 57 radiolabeled 57 tolerability profile 57 angiogenesis inhibitor 57 TORISEL 57 zileuton 57 phase IIa 57 warfarin therapy 57 biologic therapy 56 blinded placebo controlled 56 pharmacodynamic 56 Cotara 56 IMC A# 56 talactoferrin 56 therapeutic regimens 56 BAY #-# 56 Phase 2b study 56 PEG Interferon lambda 56 SILENOR TM 56 NEUMUNE 56 Phase Ib 56 cardiac toxicity 56 COPAXONE R 56 pharmacogenetic 56 pralatrexate 56 administered subcutaneously 56 subgroup analyzes 56 CYT# 56 Serdaxin 56 sunitinib 56 methylnaltrexone 56 efficacy endpoints 56 LEVADEX 56 adalimumab 56 secondary efficacy endpoints 55 RGB # 55 cetrorelix 55 pharmacologic